Update in Lung Cancer 2005
- 1 April 2006
- journal article
- review article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 173 (7), 695-697
- https://doi.org/10.1164/rccm.2601008
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- Familial Lung CancerAmerican Journal of Respiratory and Critical Care Medicine, 2006
- Epidermal Growth Factor Receptor Mutations and Gene Amplification in Non–Small-Cell Lung Cancer: Molecular Analysis of the IDEAL/INTACT Gefitinib TrialsJournal of Clinical Oncology, 2005
- Mutations in the Epidermal Growth Factor Receptor and in KRAS Are Predictive and Prognostic Indicators in Patients With Non–Small-Cell Lung Cancer Treated With Chemotherapy Alone and in Combination With ErlotinibJournal of Clinical Oncology, 2005
- Erlotinib in Lung Cancer — Molecular and Clinical Predictors of OutcomeNew England Journal of Medicine, 2005
- Risk of Lung Cancer Among White and Black Relatives of Individuals With Early-Onset Lung CancerJAMA, 2005
- Ethnic Disparities in the Treatment of Stage I Non–Small Cell Lung CancerAmerican Journal of Respiratory and Critical Care Medicine, 2005
- Epidermal Growth Factor Receptor Gene and Protein and Gefitinib Sensitivity in Non–Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 2005
- The Effects of a Smoking Cessation Intervention on 14.5-Year MortalityAnnals of Internal Medicine, 2005
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004